Today's noteworthy initiations include: ADP (ADP) initiated with a Neutral at Sterne Agee CRT... Accenture (ACN) initiated with a Buy at Sterne Agee CRT... Alliance Data (ADS) initiated with a Buy at Sterne Agee CRT... Axsome Therapies (AXSM) initiated with a Buy at Brean Capital... Blue Bird (BLBD) initiated with a Buy at Stifel... Burlington Stores (BURL) initiated with a Hold at BB&T... Chimerix (CMRX) initiated with a Buy at UBS... Cimarex Energy (XEC) initiated with a Buy at SunTrust... Clovis (CLVS) initiated with a Buy at Janney Capital... Cognizant (CTSH) initiated with a Neutral at Sterne Agee CRT... Container Store (TCS) initiated with a Neutral at Goldman... Cooper Companies (COO) initiated with a Neutral at Goldman... Corcept Therapeutics (CORT) initiated with a Buy at Janney Capital... Dave & Buster's (PLAY) initiated with an Outperform at BMO Capital... EPAM Systems (EPAM) initiated with a Buy at Sterne Agee CRT... FIS (FIS) initiated with a Neutral at Sterne Agee CRT... First Data (FDC) initiated with a Buy at Sterne Agee CRT... Fiserv (FISV) initiated with a Buy at Sterne Agee CRT... Frontline (FRO) initiated with a Buy at Seaport Global... Gener8 Maritime (GNRT) initiated with a Buy at Seaport Global... Genocea (GNCA) initiated with a Buy at UBS... Geron (GERN) initiated with a Buy at Janney Capital... Global Payments (GPN) initiated with a Buy at Sterne Agee CRT... Globant (GLOB) initiated with a Buy at Sterne Agee CRT... Harris (HRS) initiated with a Buy at Jefferies... Horizon Pharma (HZNP) initiated with a Buy at Goldman... Infosys (INFY) initiated with a Neutral at Sterne Agee CRT... Kate Spade (KATE) initiated with a Neutral at Goldman... Marinus Pharmaceuticals (MRNS) initiated with an Outperform at RBC Capital... MasterCard (MA) initiated with a Buy at Sterne Agee CRT... MicroVision (MVIS) initiated with a Buy at Rodman & Renshaw... Monro Muffler (MNRO) initiated with a Neutral at Goldman... Newfield Exploration (NFX) initiated with a Neutral at SunTrust... Orbital ATK (OA) initiated with a Buy at UBS... Paychex (PAYX) initiated with a Neutral at Sterne Agee CRT... Relypsa (RLYP) initiated with a Buy at H.C. Wainwright... Republic Services (RSG) initiated with an Overweight at JPMorgan... Ross Stores (ROST) initiated with a Buy at BB&T... Rubicon Project (RUBI) initiated with a Buy at Jefferies... Sangamo (SGMO) initiated with a Buy at Janney Capital... Skyworks (SWKS) initiated with a Buy at Chardan... TJX (TJX) initiated with a Buy at BB&T... TopBuild (BLD) initiated with an Overweight at Stephens... Unit Corp. (UNT) initiated with a Buy at SunTrust... Upland Software (UPLD) initiated with a Buy at Roth Capital... Virtusa (VRTU) initiated with a Neutral at Sterne Agee CRT... Visa (V) initiated with a Buy at Sterne Agee CRT... Waste Connections (WCN) initiated with an Overweight at JPMorgan... Waste Management (WM) initiated with a Neutral at JPMorgan... Williams-Sonoma (WSM) initiated with a Neutral at Guggenheim... Wipro (WIT) initiated with an Underperform at Sterne Agee CRT... vTv Therapeutics (VTVT) initiated with a Buy at Janney Capital.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Biohaven Pharmaceutical... To see the rest of the story go to thefly.com. See Story Here

Sees Q2 adjusted EBITDA $715M-$723M. Comments taken from Q1 earnings conference call.

Latest data shows the largest indicative borrow rate increases among liquid option names include: Luminar Technologies (LAZR) 24.73% +5.07, Spring Valley Acquisition Corp (SMR) 22.39% +3.98, ImmunityBio (IBRX) 74.40% +3.41, Lucid Group (LCID) 33.21% +2.31, ALTC Acquistion Corp (ALCC) 5.21% +1.04, Beyond Meat (BYND) 59.00% +0.68, Energy Fuels (UUUU) 2.23% +0.37, SoundHound AI (SOUN) 13.94% +0.32, Microvision (MVIS) 14.83% +0.31, and Cassava Sciences (SAVA) 21.42% +0.27.

Bernstein analyst Harshita Rawat raised the firm's price target on Visa to $310 from $304 and keeps an Outperform rating on the shares. The firm notes Visa delivered a strong Q2 and intact 2024 guidance. Going into the quarter, there were growing concerns regarding negative revisions due to multi-year low FX volatility and somewhat high volumes baked into the guide. The beat in the quarter and management commentary regarding the second half of the year may lead to consensus numbers going up modestly, Bernstein adds.

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here

IBM (IBM) is scheduled to report results of its fiscal first quarter after the market close on April 24, with a conference call scheduled for 5:00 pm ET. What to watch... To see the rest of the story go to thefly.com. See Story Here

Check out this morning's top movers from around Wall Street, compiled by The Fly. UP AFTER EARNINGS... To see the rest of the story go to thefly.com. See Story Here

Wedbush analyst Moshe Katri raised the firm's price target on Visa to $300 from $280 and keeps an Outperform rating on the shares. The firm notes Visa reported stronger than expected Q2/FY24 results, while reiterating FY24 guidance.

Citi raised the firm's price target on Visa to $321 from $314 and keeps a Buy rating on the shares. the company's March quarter results featured a top- and bottom-line beat and while the reiterated fiscal 2024 outlook implies lower second half of the year revenues, a modest step-up in growth remains embedded and the low double-digit exit rate bodes well for fiscal 2025, the analyst tells investors in a research note. The firm says the clarity on Visa's revenue trajectory and breadth of opportunity should support the multiple.